Company Analysis

Incannex Healthcare Inc. (IXHL)

Nasdaq: IXHL · Pharmaceutical Preparations · filing with the SEC since 2021
Grade4.2
◀ Past 2.1● Present 4.5▶ Future 5.3
5 est.

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

7 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Incannex Healthcare Inc.’s names, not what it holds today.

Patents granted
7
7 utility, 1976 to Dec 31, 2025
Granted in 2025
1
Against 1 in 2024 and none in 2023
Applications published
4
since 2001, to Dec 31, 2025
Names they are printed under
2
a subsidiary
By yearGrantedApplications published
'20'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Pharmaceuticals4
Organic fine chemistry2
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name2 counted
APIRx Pharmaceutical USA, LLC a subsidiary
US, as the owner printed on each patent
7 granted
3 published
APIRx Pharmaceutical USA, LLC a subsidiary
named as the applicant on its applications, in US
0 granted
1 published
Names not counted (1)
Incannex Healthcare Inc.
Most of its patents print AU; this name counts in US. 0 granted and 5 published under it are not counted.
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Jun 10, 202512,324,789Method to treat psoriasisPharmaceuticalsAPIRx Pharmaceutical USA, LLC
Feb 6, 202411,890,361Oral care composition comprising cannabinoidsOrganic fine chemistryAPIRx Pharmaceutical USA, LLC
Nov 1, 202211,484,510Method to treat vitiligoPharmaceuticalsAPIRx Pharmaceutical USA, LLC
Aug 17, 202111,091,455Process to extract and purify delta-9-tetrahydrocannabinolOrganic fine chemistryAPIRx Pharmaceutical USA, LLC
Jul 13, 202111,058,646Anti-microbial compositions comprising cannabinoidsPharmaceuticalsAPIRx Pharmaceutical USA, LLC
Mar 30, 202110,959,978Suppositories comprising cannabinoidsPharmaceuticalsAPIRx Pharmaceutical USA, LLC
Nov 24, 202010,842,786Chewing gum composition comprising cannabinoids and nicotinePharmaceuticalsAPIRx Pharmaceutical USA, LLC
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Aug 3, 20232023/0241085CANNABINOID AND SUGAR ALCOHOL COMPLEX, METHODS TO MAKE AND USEFood chemistryAPIRx Pharmaceutical USA, LLC
Feb 16, 20232023/0050166METHOD TO TREAT VITILIGOPharmaceuticalsAPIRx Pharmaceutical USA, LLC
Sep 29, 20222022/0304925SUPPOSITORIES COMPRISING CANNABINOIDSPharmaceuticalsAPIRx Pharmaceutical USA, LLC
Oct 22, 20202020/0330339ORAL CARE COMPOSITION COMPRISING CANNABINOIDSOrganic fine chemistryAPIRx Pharmaceutical USA, LLC · patent 11,890,361 granted from it

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton IXHL · research, not advice